Reproductive Medicine Associates of New Jersey
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Reproductive Medicine Associates of New Jersey sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).
Reproductive Medicine Associates of New Jersey: 51 sponsored US clinical trials, 7 recruiting.
Reproductive Medicine Associates of New Jersey sponsors 51 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 38 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Infertility, with 6 trials.
Top-decile sponsor footprint
Reproductive Medicine Associates of New Jersey ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
38 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Where Reproductive Medicine Associates of New Jersey enrollment is open (later-stage tilt)
7 recruiting of 51 indexed (14% open); 38 completed (75%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Infertility (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Reproductive Medicine Associates of New Jersey: open-pipeline peers nationwide
Peers matched on 51 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Reproductive Medicine Associates of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 51 trials (± recruiting share)
- Colgate Palmolive · 51 trials · 6% recruiting
- MedtronicNeuro · 51 trials · 4% recruiting
- Ohio University · 51 trials · 10% recruiting
- Texas Woman's University · 51 trials · 6% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- Virginia Commonwealth University · 14% recruiting · 558 trials
- Fate Therapeutics · 14% recruiting · 22 trials
- InMode MD · 14% recruiting · 22 trials
Related
What to do with this Reproductive Medicine Associates of New Jersey page
51 registered trials is a research-attention snapshot, not an endorsement of Reproductive Medicine Associates of New Jersey or any single study.
- 7 of Reproductive Medicine Associates of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Infertility is the condition Reproductive Medicine Associates of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infertility trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Reproductive Medicine Associates of New Jersey pipeline card: 51 registered trials from official public datasets.Report a data error.